Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Cash from Operations (2023 - 2025)

CG Oncology filings provide 3 years of Cash from Operations readings, the most recent being 36170000.0 for Q4 2025.

  • On a quarterly basis, Cash from Operations fell 75.06% to 36170000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 132300000.0, a 68.08% decrease, with the full-year FY2025 number at 132300000.0, down 68.08% from a year prior.
  • Cash from Operations hit 36170000.0 in Q4 2025 for CG Oncology, up from 38930000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 7986000.0 in Q1 2023 to a low of 38930000.0 in Q3 2025.
  • Median Cash from Operations over the past 3 years was 18391000.0 (2024), compared with a mean of 21391000.0.
  • Biggest five-year swings in Cash from Operations: plummeted 225.72% in 2024 and later fell 12.55% in 2025.
  • CG Oncology's Cash from Operations stood at 14645000.0 in 2023, then tumbled by 41.09% to 20662000.0 in 2024, then plummeted by 75.06% to 36170000.0 in 2025.
  • The last three reported values for Cash from Operations were 36170000.0 (Q4 2025), 38930000.0 (Q3 2025), and 27923000.0 (Q2 2025) per Business Quant data.